Yushin Company (6482) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
21 Jul, 2026Executive summary
Net sales for the first quarter ended June 30, 2025, decreased 4.8% year-over-year to ¥5,321 million amid global economic uncertainty and sluggish orders, despite growth in Asia.
Operating profit rose 28.6% year-over-year to ¥158 million due to improved gross margin, while ordinary profit fell 27.0% to ¥119 million, impacted by foreign exchange losses.
Profit attributable to owners of parent dropped 30.2% year-over-year to ¥72 million.
Financial highlights
Gross profit was ¥2,170 million, nearly flat year-over-year, with a gross margin improvement offsetting lower sales.
Basic earnings per share for the quarter was ¥2.13, down from ¥3.06 in the prior year.
Comprehensive income fell sharply to ¥91 million from ¥714 million a year earlier, mainly due to lower profit and negative foreign currency translation adjustments.
Outlook and guidance
Full-year FY2026 guidance maintained: net sales ¥25,000 million (+4.3% YoY), operating profit ¥2,200 million (+14.9% YoY), profit attributable to owners of parent ¥1,500 million (+11.4% YoY), EPS ¥44.07.
Dividend forecast for FY2026 remains undecided; FY2025 annual dividend was ¥20.00 per share.
Latest events from Yushin Company
- Sales and operating profit surged, but ordinary profit fell on forex losses; outlook steady.6482
Q2 202521 Jul 2026 - Sales surged 19.7% year-over-year, but profit margins narrowed on higher costs.6482
Q1 202521 Jul 2026 - Net sales and profit grew in FY2025, but FY2026 guidance signals declines amid global uncertainty.6482
Q4 202521 Jul 2026 - Net sales rose 14.5% year-over-year, with robust growth in Japan and Europe.6482
Q3 202521 Jul 2026 - Profits fell sharply on weak medical equipment sales, but dividends and buybacks are maintained.6482
Q2 202621 Jul 2026 - Profits and sales fell sharply in FY2026, but a strong rebound is forecast for FY2027.6482
Q4 202621 Jul 2026 - Profits and sales fell sharply year-over-year, with Europe showing the largest decline.6482
Q3 202621 Jul 2026